Latest Cameron Health Stories
Humility of Mary Health Partners is among the first healthcare providers in the country to implant the world’s first commercially available subcutaneous implantable defibrillator.
New ICD device technology is changing the CRM market for a population with heart disease on the rise. Vancouver, Canada (PRWEB) April 16, 2013 Heart
New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular heart rhythms, leaving them misinformed about how the device may affect quality of life.
A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to an 18 year-old patient.